BriaCell Therapeutics Corp (TSX:BCT)
C$ 1.2 -0.01 (-0.83%) Market Cap: 43.42 Mil Enterprise Value: 42.21 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 35/100

Briacell Therapeutics Corp at SNN Network Summer Event (Virtual) Transcript

Aug 18, 2021 / 02:30PM GMT
Release Date Price: C$7.14 (+7.21%)
Unidentified Participant

Good day and welcome to SNN Network Summer Virtual Event. Our next presenting company is BriaCell Therapeutics. It is now my pleasure to turn the floor over to Bill Williams, President and CEO of BriaCell Therapeutics. Sir, the floor is yours.

Bill Williams
BriaCell Therapeutics Corp. - President, CEO, and Director

Thanks so much and thanks again for inviting me to this event. And I should mention, of course, that in this presentation, there will be forward-looking statements.

I'm going to use our capitalization structure table to give you a little bit of background on the company. The company grew out of a technology developed by Dr. Charles Wiseman who came out of MD Anderson, was affiliated with USC. And when he was at the St. Vincent's Medical Center in Los Angeles, developed our technology back in the early 2000s, had a funding hiatus. But then the company did manage to get funded back in late 2014 and into the clinic into 2017 and 2018, which I'll be discussing.

We eventually did up list from the TSX Venture Exchange in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot